Brain Tumor Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report by Type (Primary, Secondary), Product, Diagnosis (MRI, CT, PET-CT), Therapeutics, End Use, and Region with Growth Forecasts, 2025-2030

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Product
1.2.3. Diagnosis
1.2.4. Therapeutics
1.2.5. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis

4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Primary
4.4.1. Primary Market, 2018-2030 (USD Million)
4.4.2. Meningioma
4.4.2.1. Meningioma Market, 2018-2030 (USD Million)
4.4.3. Gliomas
4.4.3.1. Gliomas Market, 2018-2030 (USD Million)
4.4.4. Astrocytomas
4.4.4.1. Astrocytomas Market, 2018-2030 (USD Million)
4.4.5. Pituitary Tumors
4.4.5.1. Pituitary Tumors Market, 2018-2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market, 2018-2030 (USD Million)
4.5. Secondary
4.5.1. Secondary Market, 2018-2030 (USD Million)

5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Stains & Varnishes
5.4.1. Stains & Varnishes Market, 2018-2030 (USD Million)
5.5. Shellacs
5.5.1. Shellacs Market, 2018-2030 (USD Million)
5.6. Lacquers
5.6.1. Lacquers Market, 2018-2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018-2030 (USD Million)

6.1. Diagnosis Market Share, 2024 & 2030
6.2. Diagnosis Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
6.4. MRI
6.4.1. MRI Market, 2018-2030 (USD Million)
6.5. CT Scan
6.5.1. CT Scan Market, 2018-2030 (USD Million)
6.6. Tissue Sampling
6.6.1. Tissue Sampling Market, 2018-2030 (USD Million)
6.7. PET-CT scan
6.7.1. PET-CT scan Market, 2018-2030 (USD Million)
6.8. Cerebral Arteriogram
6.8.1. Cerebral Arteriogram Market, 2018-2030 (USD Million)
6.9. Lumbar Puncture
6.9.1. Lumbar Puncture Market, 2018-2030 (USD Million)
6.10. Molecular Testing
6.10.1. Molecular Testing Market, 2018-2030 (USD Million)
6.11. EEG
6.11.1. EEG Market, 2018-2030 (USD Million)
6.12. Others
6.12.1. Others Market, 2018-2030 (USD Million)

7.1. Therapeutics Market Share, 2024 & 2030
7.2. Therapeutics Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Therapeutics, 2018 to 2030 (USD Million)
7.4. Surgery
7.4.1. Surgery Market, 2018-2030 (USD Million)
7.5. Radiation Therapy
7.5.1. Radiation Therapy Market, 2018-2030 (USD Million)
7.6. Chemotherapy
7.6.1. Chemotherapy Market, 2018-2030 (USD Million)
7.7. Immunotherapy
7.7.1. Immunotherapy Market, 2018-2030 (USD Million)
7.8. Targeted Therapy
7.8.1. Targeted Therapy Market, 2018-2030 (USD Million)
7.9. Others
7.9.1. Others Market, 2018-2030 (USD Million)

8.1. End Use Market Share, 2024 & 2030
8.2. End Use Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Hospitals
8.4.1. Hospitals Market, 2018-2030 (USD Million)
8.5. Oncology Treatment Centers
8.5.1. Oncology Treatment Centers Market, 2018-2030 (USD Million)
8.6. Others
8.6.1. Others Market, 2018-2030 (USD Million)

9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Framework
9.4.2.3. Competitive Insights
9.4.2.4. U.S. Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Framework
9.4.3.3. Competitive Insights
9.4.3.4. Canada Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Framework
9.4.4.3. Competitive Insights
9.4.4.4. Mexico Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5. Europe
9.5.1. Europe Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
9.5.2. UK
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Framework
9.5.2.3. Competitive Insights
9.5.2.4. UK Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Framework
9.5.3.3. Competitive Insights
9.5.3.4. Germany Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.4. France
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Framework
9.5.4.3. Competitive Insights
9.5.4.4. France Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key Country Dynamics
9.5.5.2. Regulatory Framework
9.5.5.3. Competitive Insights
9.5.5.4. Italy Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key Country Dynamics
9.5.6.2. Regulatory Framework
9.5.6.3. Competitive Insights
9.5.6.4. Spain Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key Country Dynamics
9.5.7.2. Regulatory Framework
9.5.7.3. Competitive Insights
9.5.7.4. Norway Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.8. Denmark
9.5.8.1. Key Country Dynamics
9.5.8.2. Regulatory Framework
9.5.8.3. Competitive Insights
9.5.8.4. Denmark Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.9. Sweden
9.5.9.1. Key Country Dynamics
9.5.9.2. Regulatory Framework
9.5.9.3. Competitive Insights
9.5.9.4. Sweden Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Framework
9.6.2.3. Competitive Insights
9.6.2.4. Japan Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.3. China
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Framework
9.6.3.3. Competitive Insights
9.6.3.4. China Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.4. India
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Framework
9.6.4.3. Competitive Insights
9.6.4.4. India Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.5. South Korea
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Framework
9.6.5.3. Competitive Insights
9.6.5.4. South Korea Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.6. Australia
9.6.6.1. Key Country Dynamics
9.6.6.2. Regulatory Framework
9.6.6.3. Competitive Insights
9.6.6.4. Australia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key Country Dynamics
9.6.7.2. Regulatory Framework
9.6.7.3. Competitive Insights
9.6.7.4. Thailand Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7. Latin America
9.7.1. Latin America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key Country Dynamics
9.7.2.2. Regulatory Framework
9.7.2.3. Competitive Insights
9.7.2.4. Brazil Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key Country Dynamics
9.7.3.2. Regulatory Framework
9.7.3.3. Competitive Insights
9.7.3.4. Argentina Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.8. MEA
9.8.1. MEA Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key Country Dynamics
9.8.2.2. Regulatory Framework
9.8.2.3. Competitive Insights
9.8.2.4. South Africa Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key Country Dynamics
9.8.3.2. Regulatory Framework
9.8.3.3. Competitive Insights
9.8.3.4. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key Country Dynamics
9.8.4.2. Regulatory Framework
9.8.4.3. Competitive Insights
9.8.4.4. UAE Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key Country Dynamics
9.8.5.2. Regulatory Framework
9.8.5.3. Competitive Insights
9.8.5.4. Kuwait Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)

10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Amgen Inc.
10.5.1.1. Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. AstraZeneca
10.5.2.1. Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. Bayer Corporation
10.5.3.1. Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. GE HealthCare
10.5.4.1. Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. F. Hoffmann-La Roche Ltd
10.5.5.1. Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Eisai Co., Ltd.
10.5.6.1. Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. Bristol-Myers Squibb Company
10.5.7.1. Overview
10.5.7.2. Financial Performance
10.5.7.3. Product Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. Pfizer Inc.
10.5.8.1. Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Shimadzu Corporation
10.5.9.1. Overview
10.5.9.2. Financial Performance
10.5.9.3. Product Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Siemens Healthineers AG
10.5.10.1. Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global brain tumor diagnosis and therapeutics market, by region, 2018-2030 (USD Million)
Table 4 Global brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 5 Global brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 6 Global brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 7 Global brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 8 Global brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 9 North America brain tumor diagnosis and therapeutics market, by country, 2018-2030 (USD Million)
Table 10 North America brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 11 North America brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 12 North America brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 13 North America brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 14 North America brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 15 U.S. brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 16 U.S. brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 17 U.S. brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 18 U.S. brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 19 U.S. brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 20 Canada brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 21 Canada brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 22 Canada brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 23 Canada brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 24 Canada brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 25 Europe brain tumor diagnosis and therapeutics market, by country, 2018-2030 (USD Million)
Table 26 Mexico brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 27 Mexico brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 28 Mexico brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 29 Mexico brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 30 Mexico brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 31 Europe brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 32 Europe brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 33 Europe brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 34 Europe brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 35 Europe brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 36 UK brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 37 UK brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 38 UK brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 39 UK brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 40 UK brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 41 Germany brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 42 Germany brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 43 Germany brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 44 Germany brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 45 Germany brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 46 France brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 47 France brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 48 France brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 49 France brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 50 France brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 51 Italy brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 52 Italy brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 53 Italy brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 54 Italy brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 55 Italy brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 56 Spain brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 57 Spain brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 58 Spain brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 59 Spain brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 60 Spain brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 61 Denmark brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 62 Denmark brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 63 Denmark brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 64 Denmark brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 65 Denmark brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 66 Sweden brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 67 Sweden brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 68 Sweden brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 69 Sweden brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 70 Sweden brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 71 Norway brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 72 Norway brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 73 Norway brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 74 Norway brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 75 Norway brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 76 Asia Pacific brain tumor diagnosis and therapeutics market, by country, 2018-2030 (USD Million)
Table 77 Asia Pacific brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 78 Asia Pacific brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 79 Asia Pacific brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 80 Asia Pacific brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 81 Asia Pacific brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 82 China brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 83 China brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 84 China brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 85 China brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 86 China brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 87 Japan brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 88 Japan brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 89 Japan brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 90 Japan brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 91 Japan brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 92 India brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 93 India brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 94 India brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 95 India brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 96 India brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 97 Australia brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 98 Australia brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 99 Australia brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 100 Australia brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 101 Australia brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 102 South Korea brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 103 South Korea brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 104 South Korea brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 105 South Korea brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 106 South Korea brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 107 Thailand brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 108 Thailand brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 109 Thailand brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 110 Thailand brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 111 Thailand brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 112 Latin America brain tumor diagnosis and therapeutics market, by country, 2018-2030 (USD Million)
Table 113 Latin America brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 114 Latin America brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 115 Latin America brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 116 Latin America brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 117 Latin America brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 118 Brazil brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 119 Brazil brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 120 Brazil brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 121 Brazil brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 122 Brazil brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 123 Argentina brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 124 Argentina brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 125 Argentina brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 126 Argentina brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 127 Argentina brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 128 Middle East & Africa Brain tumor diagnosis and therapeutics market, by country, 2018-2030 (USD Million)
Table 129 Middle East & Africa brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 130 Middle East & Africa brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 131 Middle East & Africa brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 132 Middle East & Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 133 Middle East & Africa brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 134 South Africa brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 135 South Africa brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 136 South Africa brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 137 South Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 138 South Africa brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 139 Saudi Arabia brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 140 Saudi Arabia brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 141 Saudi Arabia brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 142 Saudi Arabia brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 143 Saudi Arabia brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 144 UAE brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 145 UAE brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 146 UAE brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 147 UAE brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 148 UAE brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)
Table 149 Kuwait brain tumor diagnosis and therapeutics market, by type, 2018-2030 (USD Million)
Table 150 Kuwait brain tumor diagnosis and therapeutics market, by product, 2018-2030 (USD Million)
Table 151 Kuwait brain tumor diagnosis and therapeutics market, by diagnosis, 2018-2030 (USD Million)
Table 152 Kuwait brain tumor diagnosis and therapeutics market, by therapeutics, 2018-2030 (USD Million)
Table 153 Kuwait brain tumor diagnosis and therapeutics market, by end use, 2018-2030 (USD Million)

Figure 1 Brain tumor diagnosis and therapeutics market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Type and product outlook (USD Million)
Figure 10 Diagnosis and therapeutics outlook (USD Million)
Figure 11 End use outlook (USD Million)
Figure 12 Competitive landscape
Figure 13 Brain tumor diagnosis and therapeutics market dynamics
Figure 14 Brain tumor diagnosis and therapeutics market: Porter’s five forces analysis
Figure 15 Brain tumor diagnosis and therapeutics market: PESTLE analysis
Figure 16 Brain tumor diagnosis and therapeutics market: Type segment dashboard
Figure 17 Brain tumor diagnosis and therapeutics market: Type market share analysis, 2024 & 2030
Figure 18 Primary market, 2018-2030 (USD Million)
Figure 19 Meningioma market, 2018-2030 (USD Million)
Figure 20 Gliomas market, 2018-2030 (USD Million)
Figure 21 Astrocytomas market, 2018-2030 (USD Million)
Figure 22 Pituitary tumors market, 2018-2030 (USD Million)
Figure 23 Others market, 2018-2030 (USD Million)
Figure 24 Secondary market, 2018-2030 (USD Million)
Figure 25 Brain tumor diagnosis and therapeutics market: Product segment dashboard
Figure 26 Brain tumor diagnosis and therapeutics market: Product market share analysis, 2024 & 2030
Figure 27 Stains & varnishes market, 2018-2030 (USD Million)
Figure 28 Shellacs market, 2018-2030 (USD Million)
Figure 29 Lacquers market, 2018-2030 (USD Million)
Figure 30 Others market, 2018-2030 (USD Million)
Figure 31 Brain tumor diagnosis and therapeutics market: Diagnosis segment dashboard
Figure 32 Brain tumor diagnosis and therapeutics market: Diagnosis market share analysis, 2024 & 2030
Figure 33 MRI market, 2018-2030 (USD Million)
Figure 34 CT scan market, 2018-2030 (USD Million)
Figure 35 Tissue sampling market, 2018-2030 (USD Million)
Figure 36 PET-CT scan market, 2018-2030 (USD Million)
Figure 37 Cerebral arteriogram market, 2018-2030 (USD Million)
Figure 38 Lumbar puncture market, 2018-2030 (USD Million)
Figure 39 Molecular testing market, 2018-2030 (USD Million)
Figure 40 EEG market, 2018-2030 (USD Million)
Figure 41 Others market, 2018-2030 (USD Million)
Figure 42 Brain tumor diagnosis and therapeutics market: Therapeutics segment dashboard
Figure 43 Brain tumor diagnosis and therapeutics market: Therapeutics market share analysis, 2024 & 2030
Figure 44 Surgery market, 2018-2030 (USD Million)
Figure 45 Radiation therapy market, 2018-2030 (USD Million)
Figure 46 Chemotherapy market, 2018-2030 (USD Million)
Figure 47 Immunotherapy market, 2018-2030 (USD Million)
Figure 48 Targeted therapy market, 2018-2030 (USD Million)
Figure 49 Others market, 2018-2030 (USD Million)
Figure 50 Brain tumor diagnosis and therapeutics market: End use segment dashboard
Figure 51 Brain tumor diagnosis and therapeutics market: End use market share analysis, 2024 & 2030
Figure 52 Hospitals market, 2018-2030 (USD Million)
Figure 53 Oncology treatment centers market, 2018-2030 (USD Million)
Figure 54 Others market, 2018-2030 (USD Million)
Figure 55 Brain tumor diagnosis and therapeutics market revenue, by region
Figure 56 Regional marketplace: Key takeaways
Figure 57 Regional marketplace: Key takeaways
Figure 58 North America brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 59 U.S. country dynamics
Figure 60 U.S. brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 61 Canada country dynamics
Figure 62 Canada brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 63 Mexico country dynamics
Figure 64 Mexico brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 65 Europe brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 66 UK country dynamics
Figure 67 UK brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 68 Germany country dynamics
Figure 69 Germany brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 70 France country dynamics
Figure 71 France brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 72 Italy country dynamics
Figure 73 Italy brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 74 Spain country dynamics
Figure 75 Spain brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 76 Norway country dynamics
Figure 77 Norway brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 78 Sweden country dynamics
Figure 79 Sweden brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 80 Denmark country dynamics
Figure 81 Denmark brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 82 Asia Pacific brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 83 Japan country dynamics
Figure 84 Japan brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 85 China country dynamics
Figure 86 China brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 87 India country dynamics
Figure 88 India brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 89 Australia country dynamics
Figure 90 Australia brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 91 South Korea country dynamics
Figure 92 South Korea brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 93 Thailand country dynamics
Figure 94 Thailand brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 95 Latin America brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 96 Brazil country dynamics
Figure 97 Brazil brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 98 Argentina country dynamics
Figure 99 Argentina brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 100 MEA brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 101 South Africa country dynamics
Figure 102 South Africa brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 103 Saudi Arabia country dynamics
Figure 104 Saudi Arabia brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 105 UAE country dynamics
Figure 106 UAE brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 107 Kuwait country dynamics
Figure 108 Kuwait brain tumor diagnosis and therapeutics market, 2018-2030 (USD Million)
Figure 109 Company categorization
Figure 110 Company market position analysis
Figure 111 Strategic framework